Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Operating Expenses | 8,337 | 8,079 | 27,858 | 8,020 | 7,797 |
| Operating Income | -8,337 | -8,079 | -27,858 | -8,020 | -7,797 |
| Other Income | -2,559 | 144 | 279 | 1,284 | 1,765 |
| Pre-tax Income | -10,896 | -7,935 | -27,579 | -6,736 | -6,032 |
| Net Income Continuous | -10,896 | -7,935 | -27,579 | -6,736 | -6,032 |
| Net Income | $-10,896 | $-7,935 | $-27,579 | $-6,736 | $-6,032 |
| EPS Basic Total Ops | -0.66 | -0.48 | -1.94 | -0.54 | -0.54 |
| EPS Basic Continuous Ops | -0.66 | -0.48 | -2.01 | -0.52 | -0.51 |
| EPS Diluted Total Ops | -0.66 | -0.48 | -1.94 | -0.54 | -0.54 |
| EPS Diluted Continuous Ops | -0.66 | -0.48 | -2.01 | -0.52 | -0.51 |
| EBITDA(a) | $-8,068 | $-7,848 | $-27,629 | $-7,768 | $-7,524 |